SciELO - Scientific Electronic Library Online

vol.72 issue5The Argentine Health System: Organization and financial featuresHyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO


Medicina (Buenos Aires)

Print version ISSN 0025-7680


KORIN, Jorge. Bleeding during anti-vitamin K treatment: Incidence, risk factors and comparison with the new oral anticoagulants. Medicina (B. Aires) [online]. 2012, vol.72, n.5, pp.419-424. ISSN 0025-7680.

Bleeding is the main complication of oral anticoagulants, anti-vitamin K or new drugs such as anti-factor Xa or anti-thrombin agents. Risk factors associated with bleeding during warfarin therapy are discussed. For the new drugs no published data is available yet. Comparative frequencies of major bleeding during anticoagulation in atrial fibrillation and venous thromboembolism are shown. Beyond the intrinsic properties of the classic and new agents, patients characteristics and co-morbidities and an appropriate management of the antithrombotic therapy will be the factors associated with bleeding incidence in real life.

Keywords : Bleeding; Anti-vitamin K; Risk factors.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License